Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Aphios Corp.
DescriptionCombination therapy comprising protein kinase C (PKC) agonists with or without histone deacetylase (HDAC) inhibitors
Molecular Target Protein kinase C (PKC) ; Histone deacetylase (HDAC)
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase I/II
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV latency
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today